medigraphic.com

2007, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2007; 45 (1)

Risk Factors Associated with Intrauterine Growth Delay

Arriola OC, Vega MG, Hernández LA

Language: Spanish
References: 39
Page: 5-12
PDF size: 104.45 Kb.


ABSTRACT

Introduction: the term intrauterine growth delay (IGD) is used to refer a fetus with weight at birth lower than the 10th percentile for their gestational age.
Objective: to determine the prevalence and to identify risk factors associated with intrauterine growth delay in patients with normal fetal growth curves.
Material and methods: this study was made at General Hospital in Queretaro, Queretaro. There were included 70 obstetric patients with newborn with intrauterine growth delay (cases) and it was compared with 70 control patients with newborn without intrauterine growth delay.
Results: there were studied 70 cases of a total of 192 registered during the period of this study. There was a prevalence of 2.5. Of all the newborn with intrauterine growth delay, 40 (47.2 %) were female and 30 (42.8 %) were male, relating with age, mothers below 20 and above 30 were not show significant differences The risk factors associated were mainly inadequate pregnant women weight (OR 4.84, IC 95 % = 1.56 a 16.1) and less than five medical appointments for medical control during prenatal period ( OR 6.0, IC 95 % = 2048 a 14.81) , hypertensive disease during pregnancy (OR 5.09, IC 95 % = 1.4 to 20.21) and cervicovaginal infections (OR 5.09. IC 95 % = 1.52 to 21.56).
Conclusions: it is necessary to pay more attention to pregnant teenagers and also to general pregnant women to receive an adequate prenatal control in order to detect patients with risk of IGD and of this way to diminish morbidity and mortality in the newborn.


REFERENCES

  1. 1. Read MS, Catz C, Grave G, McNellis D, Warshaw JB. Intrauterine growth retardation-identification of research needs and goals. National Institute of Child Health and Human Development of USA (NICHHD). Semin Perinatol 1984;8:2-4.

  2. 2. Lubchenco L, Hausman C, Dressler M, Boyd E. Intrauterine growth as estimated from liveborn birth weight data at 24 to 42 weeks gestation. Pediatrics 1963;32:793-800.

  3. 3. Usher RH, McLean FH. Intrauterine growth of liveborn Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks after gestation. J Pediatr 1969;74:901-910.

  4. 4. Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976;126:555-564.

  5. 5. Largo RH, Wailli R, Duc G, Fanconi A, Prader A. Evaluation of perinatal growth. Helv Pediatr Acta 1980;35:419-436.

  6. 6. Gairdner D, Pearson J. A growth chart for premature and other infants. Arch Dis Child 1971;46:783-787.

  7. 7. Malvehy J, Fontan F, Iglesias J, Pérez-Procuna XM, Espigol D, Aragón C, et al. Relation of birth weight and gestational age in a population of newborn infants at the Valle de Hebron Maternity Hospital. An Esp Pediatr 1988;28(6):497-502.

  8. 8. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P. An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age. Acta Pediatr Scand 1991;80:756-762.

  9. 9. Ballabriga A, Carrascosa A. Retraso de crecimiento intrauterino. En: Ballabriga A, Carrascosa A, editores. Nutrición en la infancia y adolescencia. España: Ergón; 1998. p. 1-32.

  10. Ferrandez A, Rueda C, Labena C, Ouga B. Están-dares longitudinales normales del crecimiento, edad ósea y maduración intelectual de los niños aragoneses. España, Zaragoza: Diputación Ge-neral de Aragón; 1998.

  11. Miller HC, Merrit TA. Fetal growth in humans. Chicago, Il: Year Book Medical Publishers; 1979.

  12. UNICEF. Estado Mundial de la Infancia. 1992;4:75.

  13. Gomella TL, Cunningham MD. Neonatology. Third edition. USA: McGraw-Hill/Appleton and Lange; 1994.

  14. Bortman M. Factores de riesgo de bajo peso al nacer. Rev Panam Salud Publica/Pan Am J Public Health 1998;3(5):314-321.

  15. Donoso S, Donoso D, Villarroel del P. Morta-lidad perinatal e infantil y el bajo peso. Rev Chil Obstet Ginecol 2004;69(3):203-208.

  16. Instituto Nacional de Estadísticas. Anuarios de demografía y estadísticas vitales 1991-2001. Chile: Instituto Nacional de Estadísticas; 2002.

  17. Dirección Nacional de Estadísticas de Salud de la República de Cuba. Anuario estadístico de salud. 2001. Disponible en www.sld.cu/anuario/ indice. html

  18. Secretaría de Salud. Boletín de información esta-dística: Daños a la salud. Volumen II. México: Secretaría de Salud; 1997. (Volumen II).

  19. Miller HC. Prenatal factors affecting intrauterine growth retardation. Clin Perinatol 1985;12(2): 307-318.

  20. Carrascosa A, Ballabriga A. Crecimiento intrauterino. En: Argente J, Carrascosa A, Gracía R, Rodríguez-Hierro F, editores. Tratado de endocrinología pediátrica y de la adolescencia. Segunda edición. Barcelona, España: Doyma; 2000. p. 131-153.

  21. Ballabriga A, Carrascosa A. Nutrición fetal: retraso de crecimiento intrauterino. En: Ballabriga A, Carrascosa A, editores. Nutrición en la infancia y adolescencia. Segunda edición. Madrid, España: Ergón; 2001. p. 1-481.

  22. Job JC. Retraso del crecimiento e hipocre-cimiento de comienzo prenatal. En: Argente J, Carrascosa A, Gracía R, Rodríguez-Hierro F, editores. Tratado de endocrinología pediátrica y de la adolescencia. Segunda edición. Barcelona, España: Doyma; 2000. p. 155-75.

  23. Harding JE, Johnston BM. Nutrition and fetal growth. Reprod Fertil Dev 1995;7:539-547.

  24. Carrera JM. Crecimiento fetal normal y pato-lógico. Colección de Medicina Materno-Fetal Básica. España: Masson; 1997. p. 228.

  25. Klein JO, Remington JS. Current concepts of infections of the fetus. Infant infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders; 268-311.

  26. Winick M. Celular changes during placental and fetal growth. Am J Obstet Gynecol 1981;109:166.

  27. Krüger H, Arias-Stella J. The placenta and the newborn infant at high altitudes. Am J Obstet Gynecol 106:586-591.

  28. Jurado-García E, et al. El crecimiento intraute-rino: evaluación del peso y longitud corporal fetal en la ciudad de México. Análisis estadístico de 16 807 nacimientos consecutivos de producto único vivo. Bol Med Hosp Infant 1977:163-193.

  29. Dubowitz LM, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr 1970;77(1):1-10.

  30. Barker DJP, Hales CN, Fall CHD, Osmond C, Philips K, Clark PMS. Type 2 diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36:62-67.

  31. Potau N, Gussinye M, Sanchez-Ufarte C, Rique S, Vicens-Calvet E, Carrascosa A. Hyperin-sulinemia in pre- and post-pubertal children born small for gestational age. Hormone Res 2001;56(5-6):146-150.

  32. Karlberg J, Albertsson-Wikland K, Baber FM, Low LC, Yeung CY. Born small for gestational age: consequences for growth. Acta Pediatr 1996;417 (Suppl):8-13.

  33. Coutant R, Carel JC, Letrait M, Chatelain P, Coste J, Chaussain JL. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children. J Clin Endocrinol Metab 1970;83:1070-1074.

  34. Carrascosa A, Grupo Colaborativo Español del Estudio RCIU. Crecimiento postnatal en el retraso de crecimiento intrauterino (RCIU). Evolución hasta la talla adulta. An Esp Pediatr 2000;52:69.

  35. Lienhardt A, Carel JC, Preux PM, Coutant R, Chaussain JL. Amplitude of pubertal growth in short stature children with intrauterine growth retardation. Horm Res 2002;547:88-94.

  36. Vicens-Calvet E, Espadero RM, Carrascosa A. Longitudinal study of pubertal growth spurt in children born small for gestational age without postnatal catch-up growth. J Pediatr Endocr Met 2002;15:381-383.

  37. Capurro H, Konichezky S, Fonseca D, Caldeyro-Bracia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr 1978;93(1):120-122.

  38. Kramer MS. Determination of low birthweight. Methodological assessment and meta-analysis. Bull WHO 1987;65:663-757.

  39. Fescina RH. Aumento de peso durante el emba-razo. Bol Sanit Panam 1983;95:156.




2020     |     www.medigraphic.com